[The role of Escherichia coli strain Nissle 1917 in the gastro-intestinal diseases].
In this paper a review of the researches on the role of Escherichia coli strain Nissle 1917 (EcN) in gastrointestinal diseases was presented. EcN is a non-pathogenic strain of the Enterobacteriaceae family, which has probiotic properties. In a number of studies conducted among humans and  experimental animals the application of EcN in treatment of gastrointestinal diseases was observed. Most studies about EcN has been devoted to this organism efficacy in ulcerative colitis treatment. Comparable results were obtained, by citied authors, in the treatment (sustaining remission) of EcN and mesalazine in ulcerative colitis. Moreover, this probiotic therapy, compared to placebo, contributes to obtaining a faster remission and improvement of intestinal histopathology. The use of EcN in Crohn's disease has not been the subject of as many studies as in the case of ulcerative colitis. Assessing the importance of EcN in treatment of other gastrointestinal disorders, authors of the studies observed, that in patients with irritable bowel syndrome, who receiving this probiotic there was a pain, nausea and bloating reduction. In studies conducted among children a positive impact of EcN in prevention and treatment of diarrhea was demonstrated. Similar results were obtained in studies conducted in experimental animals. Based on the presented review it can be concluded that the strain of Escherichia coli Nissle 1917 is useful in treatment of gastrointestinal diseases, especially in treatment of ulcerative colitis. This probiotic may constitute a part of treatment of irritable bowel syndrome and diarrhea. The effectiveness of this strain in treatment of Crohn's disease is not clearly established and further research are require.
Zakład Dietetyki, Uniwersytet Medyczny we Wrocławiu.
Dorota
D
Różańska
Zakład Dietetyki, Uniwersytet Medyczny we Wrocławiu.
Bożena
B
Regulska-Ilow
Zakład Nauk Podstawowych, Uniwersytet Medyczny we Wrocławiu.
Irena
I
Choroszy-Król
Katedra i Zakład Bromatologii i Dietetyki, Uniwersytet Medyczny we Wrocławiu.
Rafał
R
Ilow
D000818:Animals; D003093:Colitis, Ulcerative / Q000178:diet therapy* / Q000382:microbiology; D003424:Crohn Disease / Q000178:diet therapy* / Q000382:microbiology; D003967:Diarrhea / Q000178:diet therapy* / Q000382:microbiology; D004926:Escherichia coli / Q000145:classification*; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000178:diet therapy* / Q000382:microbiology; D019936:Probiotics / Q000627:therapeutic use*; D013045:Species Specificity